188 related articles for article (PubMed ID: 37789275)
1. Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma.
Yu Z; Ding M; Cai Y; Lu T; Chen X; Zhou X; Wang X
BMC Cancer; 2023 Oct; 23(1):934. PubMed ID: 37789275
[TBL] [Abstract][Full Text] [Related]
2. Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma.
Xu Y; Liao W; Luo Q; Yang D; Pan M
Front Immunol; 2022; 13():761046. PubMed ID: 35145517
[TBL] [Abstract][Full Text] [Related]
3. Effects of the omega-3 fatty acid DHA on histone and p53 acetylation in diffuse large B cell lymphoma.
Bakhshi TJ; Way T; Muncy B; Georgel PT
Biochem Cell Biol; 2023 Apr; 101(2):172-191. PubMed ID: 36599133
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth.
Haery L; Lugo-Picó JG; Henry RA; Andrews AJ; Gilmore TD
Mol Cancer; 2014 Feb; 13():29. PubMed ID: 24529102
[TBL] [Abstract][Full Text] [Related]
5. Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma.
Wang J; Wang Y; Wan L; Chen X; Zhang H; Yang S; Zhong L
Front Immunol; 2023; 14():1230017. PubMed ID: 37790933
[TBL] [Abstract][Full Text] [Related]
6. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.
Zhu Y; Fu D; Shi Q; Shi Z; Dong L; Yi H; Liu Z; Feng Y; Liu Q; Fang H; Cheng S; Wang L; Tian Q; Xu P; Zhao W
Front Immunol; 2022; 13():842439. PubMed ID: 35401516
[TBL] [Abstract][Full Text] [Related]
8. Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.
Sangaletti S; Iannelli F; Zanardi F; Cancila V; Portararo P; Botti L; Vacca D; Chiodoni C; Di Napoli A; Valenti C; Rizzello C; Vegliante MC; Pisati F; Gulino A; Ponzoni M; Colombo MP; Tripodo C
EBioMedicine; 2020 Nov; 61():103055. PubMed ID: 33096480
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
Aseem SO; Jalan-Sakrikar N; Chi C; Navarro-Corcuera A; De Assuncao TM; Hamdan FH; Chowdhury S; Banales JM; Johnsen SA; Shah VH; Huebert RC
Gastroenterology; 2021 Feb; 160(3):889-905.e10. PubMed ID: 33058867
[TBL] [Abstract][Full Text] [Related]
10. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase.
Wang Y; Guo YR; Liu K; Yin Z; Liu R; Xia Y; Tan L; Yang P; Lee JH; Li XJ; Hawke D; Zheng Y; Qian X; Lyu J; He J; Xing D; Tao YJ; Lu Z
Nature; 2017 Dec; 552(7684):273-277. PubMed ID: 29211711
[TBL] [Abstract][Full Text] [Related]
11. Histone acetylation and histone acetyltransferases show significant alterations in human abdominal aortic aneurysm.
Han Y; Tanios F; Reeps C; Zhang J; Schwamborn K; Eckstein HH; Zernecke A; Pelisek J
Clin Epigenetics; 2016; 8():3. PubMed ID: 26767057
[TBL] [Abstract][Full Text] [Related]
12. Cancers with wrong HATs: the impact of acetylation.
Di Cerbo V; Schneider R
Brief Funct Genomics; 2013 May; 12(3):231-43. PubMed ID: 23325510
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
Chen X; Hu S; Han Y; Cai Y; Lu T; Hu X; Chu Y; Zhou X; Wang X
Clin Exp Med; 2023 Oct; 23(6):2601-2617. PubMed ID: 36682001
[TBL] [Abstract][Full Text] [Related]
14. Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin.
Sun N; Wang CY; Sun YQ; Ruan YJ; Huang YY; Su T; Zhou XH; Huang H; Guo WJ; He MQ; Yao RX; Lin XJ
Biomed Pharmacother; 2018 Oct; 106():267-274. PubMed ID: 29966970
[TBL] [Abstract][Full Text] [Related]
15. Expression of N
Xie Z; Li M; Hong H; Xu Q; He Z; Peng Z
Bioengineered; 2021 Dec; 12(1):6115-6133. PubMed ID: 34482808
[TBL] [Abstract][Full Text] [Related]
16. A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma.
Wang X; Lu Y; Liu Z; Zhang Y; He Y; Sun C; Li L; Zhai Q; Meng B; Ren X; Wu X; Zhang H; Wang X
Front Immunol; 2022; 13():813031. PubMed ID: 35874768
[TBL] [Abstract][Full Text] [Related]
17. DNA repair complex licenses acetylation of H2A.Z.1 by KAT2A during transcription.
Semer M; Bidon B; Larnicol A; Caliskan G; Catez P; Egly JM; Coin F; Le May N
Nat Chem Biol; 2019 Oct; 15(10):992-1000. PubMed ID: 31527837
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas.
Marquard L; Poulsen CB; Gjerdrum LM; de Nully Brown P; Christensen IJ; Jensen PB; Sehested M; Johansen P; Ralfkiaer E
Histopathology; 2009 May; 54(6):688-98. PubMed ID: 19438744
[TBL] [Abstract][Full Text] [Related]
19. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
[TBL] [Abstract][Full Text] [Related]
20. SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphoma.
Zhang Y; Qian S; Wen Q; Lei Y; Ge J; Kong X; Wang W; Wang Z; Hou H; Tang C; Wu S; Wang G; Li W; Zhang M; Zhang X; Chen Q
Clin Transl Oncol; 2023 Aug; 25(8):2438-2450. PubMed ID: 37029239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
